A Bay Area biotech company plans to move into a brand new life science development more than five times the size of its current office space after its $251 million initial public offering in September.
Biotech Company Inks Lease to Expand Bay Area Footprint on Heels of IPO
Annexon Signs Lease for Building in Healthpeak's Newest Biotech Development
By Katie Burke
CoStar News
December 29, 2020 | 2:57 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Building B
180 Kimball Way, South San Francisco, CA
- Building 2
111 Oyster Point Blvd, South San Francisco, CA
- Companies
- Annexon, Inc
Manufacturing